SPQH.DE vs. GN0M.DE

Last updated Jun 5, 2026

SPQH.DE (Global X S&P 500 Quarterly Tail Hedge UCITS ETF USD Accumulating) and GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) are both exchange-traded funds - SPQH.DE is a Defined Outcome fund tracking the Cboe S&P 500 15% WHT Quarterly 9% (-3% to -12%) Buffer Protect Index, while GN0M.DE is a Health & Biotech Equities fund tracking the Solactive Genomics. Both are passively managed. Over the past 3 years, SPQH.DE returned 5.93%/yr vs -1.90%/yr for GN0M.DE. At a 0.32 correlation, their price movements are largely independent. Both charge a 0.50% expense ratio.

Performance

SPQH.DE vs. GN0M.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Global X S&P 500 Quarterly Tail Hedge UCITS ETF USD Accumulating (SPQH.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SPQH.DE achieves a 1.52% return, which is significantly lower than GN0M.DE's 12.99% return.

SPQH.DE

• 1D: -0.13%
• 1M: 1.59%
• YTD: 1.52%
• 6M: 2.08%
• 1Y: 6.72%
• 3Y*: 5.93%
• 5Y*: —
• 10Y*: —

GN0M.DE

• 1D: 5.61%
• 1M: 13.54%
• YTD: 12.99%
• 6M: 10.44%
• 1Y: 55.70%
• 3Y*: -1.90%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SPQH.DE vs. GN0M.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
SPQH.DE Global X S&P 500 Quarterly Tail Hedge UCITS ETF USD Accumulating	1.52%	-4.41%	21.88%	6.82%
GN0M.DE Global X Genomics & Biotechnology UCITS ETF	12.99%	5.67%	-12.40%	-9.66%

Correlation

The correlation between SPQH.DE and GN0M.DE is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.26
Correlation (3Y) Calculated over the trailing 3-year period	0.31
Correlation (All Time) Calculated using the full available price history since Feb 24, 2023	0.32

Return for Risk

SPQH.DE vs. GN0M.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SPQH.DE

SPQH.DE Risk / Return Rank: 30
SPQH.DE Sharpe Ratio Rank: 26
SPQH.DE Sortino Ratio Rank: 25
SPQH.DE Omega Ratio Rank: 25
SPQH.DE Calmar Ratio Rank: 43
SPQH.DE Martin Ratio Rank: 33

GN0M.DE

GN0M.DE Risk / Return Rank: 58
GN0M.DE Sharpe Ratio Rank: 60
GN0M.DE Sortino Ratio Rank: 61
GN0M.DE Omega Ratio Rank: 54
GN0M.DE Calmar Ratio Rank: 68
GN0M.DE Martin Ratio Rank: 50

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SPQH.DE vs. GN0M.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X S&P 500 Quarterly Tail Hedge UCITS ETF USD Accumulating (SPQH.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SPQH.DE	GN0M.DE	Difference
Sharpe ratio: Return per unit of total volatility	0.92	2.00	-1.09
Sortino ratio: Return per unit of downside risk	1.32	2.82	-1.50
Omega ratio: Gain probability vs. loss probability	1.16	1.33	-0.17
Calmar ratio: Return relative to maximum drawdown	2.12	3.32	-1.20
Martin ratio: Return relative to average drawdown	4.81	8.35	-3.54
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SPQH.DE vs. GN0M.DE - Sharpe Ratio Comparison

The current SPQH.DE Sharpe Ratio is 0.92, which is lower than the GN0M.DE Sharpe Ratio of 2.00. The chart below compares the historical Sharpe Ratios of SPQH.DE and GN0M.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SPQH.DE	GN0M.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.92	2.00	-1.09
Sharpe Ratio (All Time) Calculated using the full available price history	0.68	-0.34	+1.02

Drawdowns

SPQH.DE vs. GN0M.DE - Drawdown Comparison

The maximum SPQH.DE drawdown since its inception was -17.68%, smaller than the maximum GN0M.DE drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for SPQH.DE and GN0M.DE.

Drawdown Indicators

	SPQH.DE	GN0M.DE	Difference
Max Drawdown Largest peak-to-trough decline	-17.68%	-67.19%	+49.51%
Max Drawdown (1Y) Largest decline over 1 year	-3.16%	-16.68%	+13.52%
Max Drawdown (3Y) Largest decline over 3 years	-17.68%	-48.32%	+30.64%
Current Drawdown Current decline from peak	-5.05%	-41.03%	+35.98%
Average Drawdown Average peak-to-trough decline	-4.12%	-43.13%	+39.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.39%	6.65%	-5.26%

Volatility

SPQH.DE vs. GN0M.DE - Volatility Comparison

The current volatility for Global X S&P 500 Quarterly Tail Hedge UCITS ETF USD Accumulating (SPQH.DE) is 1.63%, while Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a volatility of 8.15%. This indicates that SPQH.DE experiences smaller price fluctuations and is considered to be less risky than GN0M.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SPQH.DE	GN0M.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.63%	8.15%	-6.52%
Volatility (6M) Calculated over the trailing 6-month period	4.52%	19.69%	-15.17%
Volatility (1Y) Calculated over the trailing 1-year period	7.30%	27.68%	-20.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	10.79%	31.49%	-20.70%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	10.79%	31.49%	-20.70%

SPQH.DE vs. GN0M.DE - Expense Ratio Comparison

Both SPQH.DE and GN0M.DE have an expense ratio of 0.50%.

Dividends

SPQH.DE vs. GN0M.DE - Dividend Comparison

Neither SPQH.DE nor GN0M.DE has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both SPQH.DE and GN0M.DE in my portfolio?

SPQH.DE and GN0M.DE have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, SPQH.DE or GN0M.DE?

Both ETFs have the same 0.50% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, SPQH.DE or GN0M.DE?

SPQH.DE and GN0M.DE have the same expense ratio: 0.50% per year.

What is the main difference between SPQH.DE and GN0M.DE?

SPQH.DE is categorized as Defined Outcome, while GN0M.DE is Health & Biotech Equities. SPQH.DE tracks Cboe S&P 500 15% WHT Quarterly 9% (-3% to -12%) Buffer Protect Index, while GN0M.DE tracks Solactive Genomics.